FDA Warning Letter — ACRX Specialty Pharmacy Inc

Case 609518 — FEI 3015134033

The FDA took a Warning Letter action against ACRX Specialty Pharmacy Inc on Jul 24, 2020 (Las Vegas, NV). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
ACRX Specialty Pharmacy Inc
Date
Jul 24, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Las Vegas, NV (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.